Merck & Co., Inc. (MRK)
151.65
+1.79
(+1.19%)
USD |
NYSE |
Sep 02, 16:00
151.89
+0.24
(+0.16%)
After-Hours: 17:49
Merck Research and Development Expense (TTM) : 27.26B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.26B |
| March 31, 2026 | 21.57B |
| December 31, 2025 | 12.71B |
| September 30, 2025 | 14.26B |
| June 30, 2025 | 16.02B |
| March 31, 2025 | 15.37B |
| December 31, 2024 | 15.73B |
| September 30, 2024 | 20.80B |
| June 30, 2024 | 18.35B |
| March 31, 2024 | 28.35B |
| December 31, 2023 | 28.70B |
| September 30, 2023 | 22.54B |
| June 30, 2023 | 23.20B |
| March 31, 2023 | 13.08B |
| December 31, 2022 | 11.82B |
| September 30, 2022 | 11.61B |
| June 30, 2022 | 10.53B |
| March 31, 2022 | 10.37B |
| December 31, 2021 | 10.21B |
| September 30, 2021 | 9.895B |
| June 30, 2021 | 9.934B |
| March 31, 2021 | 9.373B |
| December 31, 2020 | 9.127B |
| September 30, 2020 | 9.051B |
| June 30, 2020 | 8.798B |
| Date | Value |
|---|---|
| March 31, 2020 | 8.928B |
| December 31, 2019 | 8.664B |
| September 30, 2019 | 8.363B |
| June 30, 2019 | 8.212B |
| March 31, 2019 | 8.299B |
| December 31, 2018 | 9.598B |
| September 30, 2018 | 9.368B |
| June 30, 2018 | 11.46B |
| March 31, 2018 | 10.96B |
| December 31, 2017 | 9.507B |
| September 30, 2017 | 8.563B |
| June 30, 2017 | 6.032B |
| March 31, 2017 | 6.142B |
| December 31, 2016 | 5.974B |
| September 30, 2016 | 6.881B |
| June 30, 2016 | 6.728B |
| March 31, 2016 | 6.429B |
| December 31, 2015 | 6.534B |
| September 30, 2015 | 6.586B |
| June 30, 2015 | 6.646B |
| March 31, 2015 | 6.683B |
| December 31, 2014 | 6.502B |
| September 30, 2014 | 6.413B |
| June 30, 2014 | 6.522B |
| March 31, 2014 | 6.754B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 15.06B |
| Eli Lilly & Co. | 14.60B |
| Pfizer Inc. | 10.82B |
| Bristol Myers Squibb Co. | 9.548B |
| Abbott Laboratories | 3.128B |